Flexbumin (Baxalta US Inc.)
Welcome to the PulseAid listing for the Flexbumin drug offered from Baxalta US Inc.. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
| NON-PROPRIETARY NAME: | Albumin Human |
| SUBSTANCE NAME: | ALBUMIN HUMAN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Flexbumin PLASMA DERIVATIVE Details:
| Item Description | Flexbumin from Baxalta US Inc. |
| LABELER NAME: | Baxalta US Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.05(g/mL) |
| START MARKETING DATE: | 2014-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0944-0495_eb67169a-753a-473f-9478-dc79ad32af30 |
| PRODUCT NDC: | 0944-0495 |
| APPLICATION NUMBER: | BLA101452 |
Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:
